Sam Isaly’s OrbiMed Advisors recently filed a Form 13D with the Securities and Exchange Commission in which reported the acquisition of 3.07 million shares of Steadymed Ltd. (NASDAQ:STDY), which ...
As of late, it has definitely been a great time to be an investor in SteadyMed Ltd. STDY. The stock has moved higher by 9.1% in the past month, while it is also above its 20 Day SMA too. This ...
SAN RAMON, Calif., June 18, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug products to treat orphan and high value ...
Holdings data is currently not available for STDY.
There are no in the selected time period.
Pursuant to its authority under the limited partnership agreement of OrbiMed Private Investments VI, LP (“OPI VI”), on August 4, 2016, OrbiMed Capital, as general partner of OPI VI, caused OPI VI to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results